Clin2
NCT06755866Possibly a fitRecruiting

Predicting chemo-radiation response with improved MRI for esophageal cancer

Esophageal Cancer

Part of Cancer, Digestive system clinical trials.

This trial uses a special MRI technique to see if it can predict how well esophageal cancer responds to chemo-radiotherapy before surgery. It may help doctors choose the best treatment plan for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
135 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have squamous cell esophageal cancer that is newly diagnosed
  • Your cancer is stage cT1b–cT2N+ or cT3–cT4 (any N)
  • You have not had chemotherapy or radiation for this cancer before
  • You do not have any other type of cancer
  • You are able to have an MRI scan safely

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04846309Recruiting· Phase 1
MRI scan to personalize radiation for esophageal cancer

This Phase 1 study uses specialized imaging (including MRI) to better “see” low-oxygen areas in esophageal cancer and help guide individualized radiation treatment. It aims to improve how radiation is planned and delivered while checking safety.

Salt Lake City, Utah
NCT06833775Not yet recruiting
Imaging scans to guide esophageal cancer treatment before surgery

This study looks at whether CT and MRI scans taken before and after chemotherapy or radiation can help doctors predict how well the treatment is working and what the cancer looks like after surgery. It may help improve treatment plans for people with esophageal cancer.

NCT07354295Recruiting
Using AI to predict treatment response in esophageal cancer

This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.

Wuhan, Other (Non U.s.)
NCT06792786Recruiting
Study of Chemo-Immunotherapy and Radiation for Esophageal Cancer with Blood Monitoring

This study tests a combination of chemotherapy, immunotherapy, and radiation for esophageal cancer that cannot be surgically removed. It also uses a simple blood test (ctDNA) to monitor your cancer's response throughout treatment.

Jinhua, Zhejiang
NCT04188535Recruiting
Scanning tumor response during radiation therapy

This study uses repeated MRI scans during radiation treatment to see how tumors change. It may help doctors adjust treatment and improve outcomes for many types of cancer.

Boston, Massachusetts
NCT06742021Recruiting
MRI test to predict immune therapy response in lung cancer

This trial uses a special MRI technique (4D FreeBreathing) to see if it can predict how well immune therapy or targeted therapy works for your lung cancer. It may help doctors choose the best treatment for you more quickly.

Kunming, Yunnan

Hear when a new Esophageal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.